US Stock MarketDetailed Quotes

TELA Bio (TELA)

Watchlist
  • 0.9756
  • +0.0155+1.61%
Close Jan 23 16:00 ET
  • 0.9998
  • +0.0242+2.48%
Post 17:17 ET
43.44MMarket Cap-1.18P/E (TTM)

TELA Bio (TELA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
9.14%20.69M
25.52%20.2M
11.55%18.52M
18.56%69.3M
3.83%17.65M
25.94%18.96M
11.02%16.09M
39.42%16.6M
41.13%58.45M
46.26%17M
Operating revenue
9.14%20.69M
25.52%20.2M
11.55%18.52M
18.56%69.3M
3.83%17.65M
25.94%18.96M
11.02%16.09M
39.42%16.6M
41.13%58.45M
46.26%17M
Cost of revenue
10.18%6.72M
21.40%6.09M
14.07%6.01M
24.38%22.81M
19.61%6.43M
30.80%6.1M
16.89%5.02M
31.31%5.27M
27.60%18.34M
55.95%5.37M
Gross profit
8.64%13.97M
27.38%14.11M
10.37%12.51M
15.90%46.49M
-3.47%11.22M
23.77%12.86M
8.55%11.07M
43.53%11.34M
48.32%40.11M
42.17%11.62M
Operating expense
-3.15%21.52M
2.40%23.19M
-3.19%22.98M
4.75%88.18M
-18.10%19.58M
8.04%22.22M
10.12%22.64M
23.97%23.74M
27.46%84.19M
35.69%23.9M
Selling and administrative expenses
-4.86%19.18M
3.26%20.98M
-4.24%20.44M
6.44%79.37M
-17.30%17.55M
10.73%20.16M
12.58%20.32M
24.85%21.35M
30.56%74.57M
42.50%21.22M
-Selling and marketing expense
-7.56%15.23M
0.95%16.86M
-5.21%16.61M
8.32%64.65M
-18.68%13.96M
13.80%16.47M
14.56%16.7M
30.11%17.52M
37.98%59.68M
47.37%17.16M
-General and administrative expense
7.20%3.95M
13.95%4.13M
0.18%3.84M
-1.11%14.72M
-11.45%3.59M
-1.21%3.68M
4.29%3.62M
5.37%3.83M
7.39%14.89M
25.02%4.05M
Research and development costs
13.54%2.35M
-5.17%2.2M
6.14%2.54M
-8.38%8.81M
-24.43%2.03M
-12.67%2.07M
-7.60%2.32M
16.62%2.39M
7.63%9.62M
-1.50%2.69M
Operating profit
19.34%-7.55M
21.51%-9.08M
15.59%-10.47M
5.40%-41.7M
31.96%-8.35M
8.01%-9.37M
-11.66%-11.57M
-10.24%-12.41M
-12.99%-44.08M
-30.08%-12.28M
Net non-operating interest income expense
10.64%-1.2M
10.74%-1.19M
8.48%-1.22M
-1.28%-5.29M
4.61%-1.28M
-0.75%-1.34M
-2.54%-1.33M
-6.90%-1.33M
-28.93%-5.22M
-14.57%-1.35M
Non-operating interest expense
-10.64%1.2M
-10.74%1.19M
-8.48%1.22M
1.28%5.29M
-4.61%1.28M
0.75%1.34M
2.54%1.33M
6.90%1.33M
28.93%5.22M
14.57%1.35M
Other net income (expense)
-54.90%152K
25.91%379K
-94.07%479K
241.69%9M
-61.12%285K
-39.61%337K
-65.40%301K
1,607.61%8.08M
312.76%2.63M
15.62%733K
Special income (charges)
--0
--0
--0
--7.58M
--0
--0
--0
--7.58M
--0
--0
-Gain on sale of business
--0
--0
--0
--7.58M
--0
--0
--0
--7.58M
--0
--0
Other non- operating income (expenses)
-54.90%152K
25.91%379K
-3.62%479K
-46.09%1.42M
-61.12%285K
-39.61%337K
-65.40%301K
5.07%497K
26,440.00%2.63M
15.62%733K
Income before tax
17.06%-8.6M
21.51%-9.89M
-98.06%-11.21M
18.60%-37.99M
27.45%-9.35M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
Income tax
0
33K
52K
-144K
-144K
0
0
0
0
Net income
17.06%-8.6M
21.25%-9.92M
-98.98%-11.26M
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
Net income continuous Operations
17.06%-8.6M
21.25%-9.92M
-98.98%-11.26M
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
Minority interest income
Net income attributable to the parent company
17.06%-8.6M
21.25%-9.92M
-98.98%-11.26M
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.06%-8.6M
21.25%-9.92M
-98.98%-11.26M
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
Basic earnings per share
54.76%-0.19
56.86%-0.22
-8.70%-0.25
34.80%-1.33
56.60%-0.23
6.67%-0.42
-10.87%-0.51
63.49%-0.23
25.00%-2.04
-1.92%-0.53
Diluted earnings per share
54.76%-0.19
56.86%-0.22
-8.70%-0.25
34.80%-1.33
56.60%-0.23
6.67%-0.42
-10.87%-0.51
63.49%-0.23
25.00%-2.04
-1.92%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 9.14%20.69M25.52%20.2M11.55%18.52M18.56%69.3M3.83%17.65M25.94%18.96M11.02%16.09M39.42%16.6M41.13%58.45M46.26%17M
Operating revenue 9.14%20.69M25.52%20.2M11.55%18.52M18.56%69.3M3.83%17.65M25.94%18.96M11.02%16.09M39.42%16.6M41.13%58.45M46.26%17M
Cost of revenue 10.18%6.72M21.40%6.09M14.07%6.01M24.38%22.81M19.61%6.43M30.80%6.1M16.89%5.02M31.31%5.27M27.60%18.34M55.95%5.37M
Gross profit 8.64%13.97M27.38%14.11M10.37%12.51M15.90%46.49M-3.47%11.22M23.77%12.86M8.55%11.07M43.53%11.34M48.32%40.11M42.17%11.62M
Operating expense -3.15%21.52M2.40%23.19M-3.19%22.98M4.75%88.18M-18.10%19.58M8.04%22.22M10.12%22.64M23.97%23.74M27.46%84.19M35.69%23.9M
Selling and administrative expenses -4.86%19.18M3.26%20.98M-4.24%20.44M6.44%79.37M-17.30%17.55M10.73%20.16M12.58%20.32M24.85%21.35M30.56%74.57M42.50%21.22M
-Selling and marketing expense -7.56%15.23M0.95%16.86M-5.21%16.61M8.32%64.65M-18.68%13.96M13.80%16.47M14.56%16.7M30.11%17.52M37.98%59.68M47.37%17.16M
-General and administrative expense 7.20%3.95M13.95%4.13M0.18%3.84M-1.11%14.72M-11.45%3.59M-1.21%3.68M4.29%3.62M5.37%3.83M7.39%14.89M25.02%4.05M
Research and development costs 13.54%2.35M-5.17%2.2M6.14%2.54M-8.38%8.81M-24.43%2.03M-12.67%2.07M-7.60%2.32M16.62%2.39M7.63%9.62M-1.50%2.69M
Operating profit 19.34%-7.55M21.51%-9.08M15.59%-10.47M5.40%-41.7M31.96%-8.35M8.01%-9.37M-11.66%-11.57M-10.24%-12.41M-12.99%-44.08M-30.08%-12.28M
Net non-operating interest income expense 10.64%-1.2M10.74%-1.19M8.48%-1.22M-1.28%-5.29M4.61%-1.28M-0.75%-1.34M-2.54%-1.33M-6.90%-1.33M-28.93%-5.22M-14.57%-1.35M
Non-operating interest expense -10.64%1.2M-10.74%1.19M-8.48%1.22M1.28%5.29M-4.61%1.28M0.75%1.34M2.54%1.33M6.90%1.33M28.93%5.22M14.57%1.35M
Other net income (expense) -54.90%152K25.91%379K-94.07%479K241.69%9M-61.12%285K-39.61%337K-65.40%301K1,607.61%8.08M312.76%2.63M15.62%733K
Special income (charges) --0--0--0--7.58M--0--0--0--7.58M--0--0
-Gain on sale of business --0--0--0--7.58M--0--0--0--7.58M--0--0
Other non- operating income (expenses) -54.90%152K25.91%379K-3.62%479K-46.09%1.42M-61.12%285K-39.61%337K-65.40%301K5.07%497K26,440.00%2.63M15.62%733K
Income before tax 17.06%-8.6M21.51%-9.89M-98.06%-11.21M18.60%-37.99M27.45%-9.35M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M
Income tax 033K52K-144K-144K0000
Net income 17.06%-8.6M21.25%-9.92M-98.98%-11.26M18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M
Net income continuous Operations 17.06%-8.6M21.25%-9.92M-98.98%-11.26M18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M
Minority interest income
Net income attributable to the parent company 17.06%-8.6M21.25%-9.92M-98.98%-11.26M18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.06%-8.6M21.25%-9.92M-98.98%-11.26M18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M
Basic earnings per share 54.76%-0.1956.86%-0.22-8.70%-0.2534.80%-1.3356.60%-0.236.67%-0.42-10.87%-0.5163.49%-0.2325.00%-2.04-1.92%-0.53
Diluted earnings per share 54.76%-0.1956.86%-0.22-8.70%-0.2534.80%-1.3356.60%-0.236.67%-0.42-10.87%-0.5163.49%-0.2325.00%-2.04-1.92%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More